X
Real-world diabetes study CONFIRMs positive comparative efficacy for Novo’s Tresiba
https://pharmaphorum.com/news/tresiba-improved-sugar-control-decreased-hypos/
Tresiba
Novo’s Tresiba primed for key ‘hypo’ label update in EU
Fast-acting insulin also approved in US